A new SPECT/CT imaging approach can accurately differentiate inflammation from fibrosis in interstitial lung disease (ILD) ...
Lung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic ...
The mechanisms linking pulmonary structure, mechanics and breathing patterns, reflux, and dysfunction of the upper gut are highly complex.
A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted cancer drug selpercatinib can significantly reduce the risk of lung cancer returning ...
He ran a myriad of tests including extensive bloodwork that checked for the rare Jo-1 antibody. When it can back positive, ...
The Rare Lung Disease Program’s mission is to provide state of the art collaborative evaluation and treatment for patients with rare lung diseases. This program exists to better understand rare lung ...
Infex Therapeutics is pushing ahead with the development of a non-cystic fibrosis bronchiectasis (NCFB) drug candidate after ...
Space-based drug labs are here! See how Varda and United Therapeutics are using microgravity to improve rare lung disease ...
Phase 3b ENCORE data assess inhaled amikacin in MAC lung disease. Read more on efficacy, safety, and patient-reported outcomes.
Sandy Sovann, 34, was diagnosed with a very rare lung disease, pulmonary alveolar proteinosis, or PAP.
Testing workers to detect cases of silicosis in young quartz stonemasons could catch the disease early and avoid the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results